Search Results

• • 15 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors

  Authors:Giovanna De Maglio, Mariaelena Casagrande, Michela Guardascione, Caterina Fontanella, Stefania Eufemia Lutrino, Karim Rihawi, et al.From:Future Oncology (Vol. 11, Issue 8) Peer-Reviewed

  Apr. 20154,484 words Report 1730LAuthor(s): Giovanna De Maglio aff1 , Mariaelena Casagrande aff2 , Michela Guardascione aff2 , Caterina Fontanella aff2 , Stefania Eufemia Lutrino aff2 , Karim Rihawi aff2 , Federica Edith Pisa aff3 , Francesco Tuniz...

• Molecular features and clinical outcome of lung malignancies in very young people

  Authors:Chiara Catania, Edoardo Botteri, Massimo Barberis, Fabio Conforti, Francesca Toffalorio, Filippo De Marinis, et al.From:Future Oncology (Vol. 11, Issue 8) Peer-Reviewed

  Apr. 20156,123 words Report 1430LAuthor(s): Chiara Catania [*] aff1 , Edoardo Botteri aff2 , Massimo Barberis aff3 , Fabio Conforti aff1 , Francesca Toffalorio aff1 , Filippo De Marinis aff1 , Sabrina Boselli aff1 , Cristina Noberasco aff1 , Angelo...

• Targeted therapy for thymic epithelial tumors: a new horizon? Review of the literature and two cases reports

  Authors:Matteo Simonelli, Paolo A Zucali, Matteo B Suter, Elena Lorenzi, Luca Rubino, Giuseppe Fatuzzo, et al.From:Future Oncology (Vol. 11, Issue 8) Peer-Reviewed

  Apr. 20156,151 words Report 1770LAuthor(s): Matteo Simonelli [*] aff1 , Paolo A Zucali aff1 , Matteo B Suter aff1 , Elena Lorenzi aff1 , Luca Rubino aff1 , Giuseppe Fatuzzo aff1 , Marco Alloisio aff2 , Armando Santoro aff1 KEYWORDS cixutumumab;...

• The investigational proteasome inhibitor ixazomib for the treatment of multiple myeloma

  Authors:Paul G Richardson, Philippe Moreau, Jacob P Laubach, Neeraj Gupta, Ai-Min Hui, Kenneth C Anderson, et al.From:Future Oncology (Vol. 11, Issue 8) Peer-Reviewed

  Apr. 201511,385 words Report 2260LAuthor(s): Paul G Richardson [*] aff1 , Philippe Moreau aff2 , Jacob P Laubach aff1 , Neeraj Gupta aff3 , Ai-Min Hui aff3 , Kenneth C Anderson aff1 , Jesús F San Miguel aff4 , Shaji Kumar aff5 KEYWORDS continuous...

• Personalized treatment of early-stage non-small-cell lung cancer: the challenging role of EGFR inhibitors

  Authors:Mariacarmela Santarpia, Giuseppe Altavilla, Vincenzo Pitini, and Rafael RosellFrom:Future Oncology (Vol. 11, Issue 8) Peer-Reviewed

  Apr. 201511,158 words Report 1850LAuthor(s): Mariacarmela Santarpia [*] aff1 , Giuseppe Altavilla aff1 , Vincenzo Pitini aff1 , Rafael Rosell aff2 aff3 aff4 KEYWORDS adjuvant therapy; EGFR mutations; EGF receptor inhibitors; non-small-cell lung...

• Adjuvant hormonal therapy and fertility preservation in premenopausal breast cancer: a survey among Italian oncologists

  Authors:Sandro Barni, Elena Collova, Antonio Frassoldati, and Domenico AmorosoFrom:Future Oncology (Vol. 11, Issue 8) Peer-Reviewed

  Apr. 20155,335 words Report 1920LAuthor(s): Sandro Barni [*] aff1 , Elena Collovà aff2 , Antonio Frassoldati aff2 , Domenico Amoroso aff3 KEYWORDS adjuvant hormone-therapy; premenopausal breast cancer Breast cancer is the most common invasive...

• Common EGFR-mutated subgroups (Del19/L858R) in advanced non-small-cell lung cancer: chasing better outcomes with tyrosine kinase inhibitors

  Authors:Noemi Reguart and Jordi RemonFrom:Future Oncology (Vol. 11, Issue 8) Peer-Reviewed

  Apr. 20158,486 words Report 1780LAuthor(s): Noemi Reguart [*] aff1 , Jordi Remon aff2 KEYWORDS afatinib; chemotherapy; Del19; EGFR ; erlotinib; gefitinib; L858R; mutations; NSCLC; TKI The introduction of targeted therapies based on recognition...

• Cervical cancer: what is the optimal age for routine testing?

  Authors:Lukas Rob, Ruth Tachezy, and Helena RobovaFrom:Future Oncology (Vol. 11, Issue 8) Peer-Reviewed

  Apr. 20152,533 words Report 1710LAuthor(s): Lukas Rob [*] aff1 , Ruth Tachezy aff2 aff3 , Helena Robova aff1 KEYWORDS cervical cancer; cytology; hrHPV; screening; screening age; screening interval Carcinoma of the uterine cervix is the fourth...

• Targeting leukemic stem cells with multifunctional bioactive polypeptide nanoparticles

  Authors:Fatih M Uckun, Sanjive Qazi, and Jianjun ChengFrom:Future Oncology (Vol. 11, Issue 8) Peer-Reviewed

  Apr. 20152,803 words Report 2280LAuthor(s): Fatih M Uckun [*] aff1 aff2 aff3 , Sanjive Qazi aff1 , Jianjun Cheng aff4 KEYWORDS biotherapy; cancer; CD19; health; leukemia; nanotechnology; personalized medicine RNA interference (RNAi) using...

• Temozolomide-based combination for advanced neuroendocrine neoplasms: a systematic review of the literature

  Authors:Omar Abdel-Rahman and Mona FouadFrom:Future Oncology (Vol. 11, Issue 8) Peer-Reviewed

  Apr. 20158,305 words Report 1690LAuthor(s): Omar Abdel-Rahman [*] aff1 , Mona Fouad aff2 KEYWORDS combination regimens; neuroendocrine neoplasms; systemic therapy; temozolomide Introduction Neuroendocrine neoplasms (NENs) develop in many...

• 'Liver-first' approach for metastatic colorectal cancer

  Authors:Marcello Donati, Gregor A Stavrou, Axel Stang, Francesco Basile, and Karl J OldhaferFrom:Future Oncology (Vol. 11, Issue 8) Peer-Reviewed

  Apr. 20156,868 words Report 1980LAuthor(s): Marcello Donati [*] aff1 aff2 , Gregor A Stavrou aff2 , Axel Stang aff3 , Francesco Basile aff1 , Karl J Oldhafer aff2 KEYWORDS colorectal liver metastasis; liver-first; metastatic cancer;...

• Use of gemcitabine-platinum in Indian patients with advanced gall bladder cancer

  Authors:Bhawna Sirohi, Sameer Rastogi, Ashish Singh, Vipul Sheth, Shaheenah Dawood, Sanjay Talole, et al.From:Future Oncology (Vol. 11, Issue 8) Peer-Reviewed

  Apr. 20155,278 words Report 1780LAuthor(s): Bhawna Sirohi [*] aff1 , Sameer Rastogi aff1 , Ashish Singh aff1 , Vipul Sheth aff1 , Shaheenah Dawood aff2 , Sanjay Talole aff3 , Mukta Ramadwar aff4 , Suyash Kulkarni aff5 , Shailesh V Shrikhande aff6...

• Monitor cancer progression without surgery, meet the technique's inventor

  Author:Gemma WestcottFrom:Future Oncology (Vol. 11, Issue 8) Peer-Reviewed

  Apr. 20151,252 words Interview 1280LAuthor(s): Mohammad Haris [*] KEYWORDS cancer; creatine kinase; MRI; patent; Sidra Medical and Research Center; surgery Q What was it that initially sparked your interest in cancer research? From a very...

• Pazopanib for the treatment of renal cell carcinoma

  Authors:Sarah J Welsh and Kate FifeFrom:Future Oncology (Vol. 11, Issue 8) Peer-Reviewed

  Apr. 20157,605 words Report 1710LAuthor(s): Sarah J Welsh aff1 , Kate Fife [*] aff1 KEYWORDS antiangiogenic; kidney; pazopanib; renal cancer; treatment; tyrosine kinase inhibitor Renal cell cancer (RCC) is the 13th most common cancer with a...

• Actual benefit of chemo-hormonal therapy in non-castrate metastatic prostate cancer

  Authors:Muhammed Bulent Akinci, Nuriye Yildirim Ozdemir, Sercan Aksoy, Didem S Dede, Arife Ulas, Nurullah Zengin, et al.From:Future Oncology (Vol. 11, Issue 8) Peer-Reviewed

  Apr. 20151,488 words Report 1840LAuthor(s): Mehmet AN Şendur [*] aff1 , Muhammed Bülent Akinci aff1 , Nuriye Yildirim Ozdemir aff1 , Sercan Aksoy aff2 , Didem S Dede aff1 , Arife Ulas aff3 , Nurullah Zengin aff1 , Bülent Yalçin aff1 KEYWORDS...